Patents
Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
04/2009
04/01/2009EP2040690A1 Inhibitors of cxcr2
04/01/2009EP2040688A1 New cxcr2 inhibitors
04/01/2009CN100473643C Preparation of bar-like zunthoxylum bungeanum acylamide
03/2009
03/31/2009US7511074 A 5-(2,3,5,6-tetrafluoro-4-trifluoromethyl-benzylamino)-benzoic acid, acid ester, sulfonic acid or amide derivatives, for treating Alzheimer's disease, Parkinson's disease and Huntington's disease, epilepsy, stroke
03/31/2009CA2356121C Novel propargylether derivatives
03/26/2009US20090082461 Deuterium-enriched modafinil
03/25/2009EP2039354A1 Compound having activity of blocking nmda receptor channel, and pharmaceutical agent using the same
03/25/2009EP2038251A1 Positively charged water-soluble prodrugs of aspirin
03/25/2009EP1670849B1 Aspartate derivatives and process for their preparation
03/25/2009CN101391969A Method for preparing N-methyl-2-(2,4-dichlorophenoxy) acetamide
03/25/2009CN101391968A N-ethyl-2-(4-chlorophenoxy) acetamide and preparation method thereof
03/24/2009US7507765 Mevalonic acid derivatives; antitumor/anticancer agents
03/24/2009CA2176373C Farnesyl derivatives and pharmaceutical compositions containing them
03/19/2009WO2009035156A1 Novel compound, process for production thereof, and use thereof
03/19/2009WO2009035003A1 Benzamide derivative, hydrogelling agent, and hydrogel
03/19/2009WO2009034457A1 Organic compounds useful for the treatment of neurodegenerative diseases, uses and methods for the preparation thereof
03/19/2009WO2009034432A2 Novel compounds active as muscarinic receptor antagonists
03/19/2009WO2009009287A3 Hormone sensitive lipase modulators and methods of use
03/19/2009US20090076155 benzoic acid derivatives, used as acetyltransferase enzyme inhibitors, used in the treatment of diseases due to defects in gene regulation predominantly cancer
03/19/2009US20090074746 Compounds to treat alzheimer's disease
03/19/2009CA2699463A1 Novel compounds active as muscarinic receptor antagonists
03/18/2009EP2036882A1 Zwitterionic connections and their use
03/18/2009EP2035380A2 Parp inhibitors
03/18/2009EP2035369A1 Therapeutic compounds
03/18/2009EP2035367A1 Ship 1 modulator prodrugs
03/18/2009EP1805129B1 (biphenyl) carboxylic acids and derivatives thereof
03/18/2009EP1713466B1 Antiparasitic composition containing an organic amine salt of closantel
03/18/2009CN101386581A Method for preparing acetsalicylamide
03/18/2009CN100469764C Vitamin D derivatives
03/17/2009US7504532 Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives, intermediates thereof and methods for their preparation
03/17/2009US7504413 N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
03/17/2009CA2412161C Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones
03/12/2009WO2009031202A1 Cinnamic acid derivatives and use thereof as ultraviolet absorber
03/12/2009WO2009005297A3 Optically active (r)-aryloxypropionic acid amides and herbicidal composition comprising same
03/12/2009US20090069432 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
03/11/2009EP1969129B1 Process for the preparation of (r)- and (s)-4-(1-aminomethyl) benzoic acid methylester-sulphate from racemic 4-(1-aminoethyl)benzoic acid methylester
03/11/2009CN100467443C 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
03/11/2009CN100466915C Menthyl half acid ester dirivatives, processes for preparing same, and uses thereof for their cooling/refreshing effect in consumable materials
03/10/2009US7501538 Erythropoietin receptor activators; inducing red blood cell production and maturation
03/10/2009CA2336853C Phenoxyacetic acid derivatives and medicinal compositions containing the same
03/05/2009WO2009027081A2 Process for preparing pentanoic diacid derivatives
03/05/2009US20090062340 Novel biaromatic compounds which activate ppary type receptors and cosmetic/pharmaceutical compositions comprised thereof
03/05/2009US20090062284 Thio-Substituted Biarylmethanesulfinyl Derivatives
03/05/2009US20090060838 Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies
03/05/2009CA2696381A1 Process for preparing pentanoic diacid derivatives
03/04/2009EP2030966A1 Benzylidene malonamide and salt thereof, ultraviolet ray absorbent, and agent for external application to the skin
03/04/2009EP1472209B1 Lipoxin a4 analogs
03/03/2009US7498460 Isophthalic acid derivatives
03/03/2009US7498457 Process for preparing solid particles of phenolic antioxidants
03/03/2009US7498292 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof
03/03/2009CA2335551C Thyroid hormone analogues and methods for their preparation
03/03/2009CA2265431C Acetoacetarylamides
02/2009
02/25/2009EP1856031B1 2-arylpropionic acid derivatives and pharmaceutical compositions containing them
02/25/2009EP1143965B1 Carbocyclic potassium channel inhibitors
02/25/2009CN101372459A Zwitterionic compounds and use thereof
02/24/2009US7495030 (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
02/19/2009US20090048458 Synthesis of 2-hydroxy-n,n-dimethyl-3-[[2-[[1(r)-(5-methyl-2-furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]amino]benzamide
02/18/2009CN101370771A Dibenzene derivatives as calcium channel blockers
02/18/2009CN100462353C Propionamide derivatives used as androgen receptor modulators
02/17/2009US7491817 Silica base, an acyl or aroyl substituent, and an acid labile dimethoxytrityl group; "universal" solid support
02/17/2009US7491752 Dendrimers; cyclization; liquid crystals
02/17/2009US7491741 Diaminopropionic acid derivatives
02/12/2009US20090042997 For lowering surface tension; improve surfactant or surface treating agent performance and to increase the fluorine efficiency; lower proportion of the expensive fluorine component is required to achieve desired levels of performance
02/11/2009EP2021345A1 Hydroxylated amide skin moisturizer
02/11/2009EP2021313A1 Biomarkers for diagnosing multiple sclerosis, and methods thereof
02/10/2009US7488844 Therapeutic agents
02/10/2009CA2336691C Ligands for metals and metal-catalyzed processes
02/05/2009WO2009016087A1 Monoamide derivatives as orexin receptor antagonists
02/05/2009WO2009016083A1 Degradation accelerator for polymers and polymer article comprising it
02/05/2009WO2009016025A1 Process for the synthesis of na- beta-alaninate and calcium pantothenate
02/05/2009CA2694276A1 Monoamide derivatives as orexin receptor antagonists
02/04/2009EP1565422B1 Vitamin d receptor modulators
02/04/2009CN100457708C Interfacial method of preparing ester-substituted diaryl carbonates
02/03/2009US7485741 Method of producing nitrile compounds from ethylenically-unsaturated compounds
02/03/2009CA2259936C Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
01/2009
01/29/2009WO2009013915A1 Inhibitor of plasminogen activator inhibitor-1
01/29/2009WO2009013293A1 Substituted cyclohexanecarboxamides useful as bace inhibitors
01/29/2009US20090030056 Novel sodium channel blockers
01/29/2009US20090029903 1,1'-(1,2-Ethynediyl)Bis-Benzene Derivatives As Ptp 1-B Inhibitors
01/28/2009EP2019090A1 Substituted beta-phenyl-alpha-hydroxy propanoic acid, synthesis method and use thereof
01/28/2009CN100455566C Novel derivatives of aminocyclohexane
01/27/2009US7482488 (E)-N-(4-methoxy-3-nitrophenyl)-3-(3,4,5-trimethoxyphenyl)-2-propenamide; as antiproliferative agents, radioprotective agents and cytoprotective agents, anticancer agents
01/27/2009CA2247443C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma
01/22/2009WO2009011654A1 Process for the preparation of cyclic spiropiperidines
01/22/2009WO2009011653A1 A process for the preparation of intermediates and their us in the synthesis of spiropiperidine compounds
01/22/2009US20090023928 Phthalamide-lanthanide complexes for use as luminescent markers
01/22/2009US20090023926 Biopolymer ionization; liquid chromatography
01/22/2009US20090023734 Treating cell proliferative disorders
01/21/2009EP2017244A2 Chiral binaphtol derivatives as alanine racemase mimics with powerful hydrogen bond donors: their use for optical resolution and optical inversion
01/21/2009EP1453774B1 Method for the arylation of olefins
01/21/2009CN101351442A Amide compounds and their use
01/21/2009CN101347533A Effective component of gamene and preparation and use thereof
01/21/2009CN100453529C Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases
01/20/2009CA2502856C Intermediates for retroviral protease inhibiting compounds
01/20/2009CA2364944C C16 unsaturated fp-selective prostaglandins analogs
01/20/2009CA2337770C Amide derivatives which are useful as cytokine inhibitors
01/20/2009CA2174061C 7-substituted quinone methides as inhibitors for unsaturated monomers
01/15/2009WO2009009287A2 Hormone sensitive lipase modulators and methods of use
01/15/2009WO2009007396A1 Nonsteroidal progesterone receptor modulators
01/15/2009US20090018058 Vitamin D Receptor Modulators
1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 157